This week in space, we witness a fascinating array of developments, from Israeli experiments aboard the ISS to Starship's latest test flight and China's rocket launch. SpacePharma's innovative lab, now with two active laboratories on the ISS, is conducting groundbreaking research on cancer treatment and biomarker discovery. The company's CEO, Yossi Yamin, presents their work on producing monoclonal antibodies and organoids, hinting at future clinical trials. Meanwhile, Israeli student experiments, funded by the Ramon Foundation, explore microgravity's effects on enzymes and antimicrobial proteins, showcasing the power of space education. The Harel Space Agency's collaboration with South Sudan's Ministry of Foreign Affairs to establish a space academy is a testament to the potential of space science for basic needs like water management and agriculture. SpaceX's Starship system, with its improved Raptor 3 engines and redesigned launch vehicle, is set for its 12th test flight, aiming for thousands of launches annually. China's LandSpace, after a setback, successfully launched its Zhuque-2E rocket, placing a 2.8-ton payload into orbit, marking a significant milestone in methane-powered rocketry. These developments highlight the rapid advancements in space technology, with each country pushing the boundaries of what's possible in the final frontier.
